Figure 2 | Scientific Reports

Figure 2

From: Comprehensive analyses of solute carrier family members identify SLC12A2 as a novel therapy target for colorectal cancer

Figure 2

Construction of a prognosis-related SLC gene signature in CRC. (A,B) The distribution of risk scores and the correspondingly survival status of patients, expression abundance of the 6-SLC gene in the training set (A) and the testing set (B). (C) Survival curves(a), ROC curves (b) and multivariate Cox regression analyses (c) in the training set. (D) Survival curves(a), ROC curves (b) and multivariate Cox regression analyses (c) in the testing set.

Back to article page